Porcine Reproductive and Respiratory Syndrome: Genomic Surveillance and Vaccine Strategies Using Bioinformatics

Abstract

Porcine reproductive and respiratory syndrome (PRRS) remains one of the most economically significant viral diseases affecting global swine production. The causative agent, porcine reproductive and respiratory syndrome virus (PRRSV), exhibits remarkable genetic diversity driven by high mutation rates and frequent recombination events. This review examines the application of bioinformatics methodologies to genomic surveillance and vaccine development, with particular emphasis on phylogenetic analysis of open reading frame 5 (ORF5), machine learning algorithms for strain classification, and reverse vaccinology pipelines for epitope identification. Integration of next-generation sequencing data with computational immunology enables rational design of broadly protective vaccines targeting conserved structural and non-structural proteins.

1. Introduction

Porcine reproductive and respiratory syndrome virus belongs to the family Arteriviridae, genus Betaarterivirus, comprising two distinct species: Betaarterivirus europensis (PRRSV-1) and Betaarterivirus americense (PRRSV-2) [1]. The virus possesses a positive-sense, single-stranded RNA genome approximately 15 kilobases in length, encoding at least 10 open reading frames (ORFs). The structural proteins include GP2, GP3, GP4, GP5, M, and N, while non-structural proteins (NSPs) 1 through 11 mediate replication, immune evasion, and host modulation [5, 6, 10].

The economic impact of PRRS stems from reproductive failure in breeding herds and respiratory disease in growing pigs, with annual losses estimated at hundreds of millions of dollars in major pork-producing nations. Genetic diversity poses the primary obstacle to effective control. The viral RNA-dependent RNA polymerase lacks proofreading activity, generating quasispecies populations within individual hosts. Recombination between co-circulating strains further accelerates antigenic drift and shift [2, 15].

Bioinformatics has transformed PRRS surveillance from targeted Sanger sequencing of ORF5 to whole-genome approaches enabling real-time tracking of viral evolution, transmission dynamics, and vaccine escape mutants. This review synthesizes current computational strategies for genomic surveillance and their translation into vaccine design pipelines.

2. Viral Genomics and Molecular Classification

2.1 Genome Organization and Protein Function

The PRRSV genome contains a 5' untranslated region (UTR), followed by ORF1a and ORF1b encoding the replicase polyproteins pp1a and pp1ab. These are proteolytically processed into 14 non-structural proteins (NSP1α, NSP1β, NSP2 through NSP12). The 3' proximal region contains ORFs 2 through 7 encoding structural proteins [10, 13].

Table 1: PRRSV genomic organization and protein functions.

2.2 Species and Lineage Classification

PRRSV-1 and PRRSV-2 share approximately 60 percent nucleotide identity across the genome. Within each species, multiple lineages and sublineages have been defined based on ORF5 phylogeny. PRRSV-2 encompasses nine major lineages, with lineage 1 (formerly North American type) and lineage 8 (highly pathogenic Chinese strains) receiving particular attention due to clinical severity [1, 15]. Sublineage 1A, 1B, 1C, and 1H designations reflect further diversification within lineage 1 [2].

The highly pathogenic PRRSV-2 lineage 8 (HP-PRRSV) emerged in China in 2006, characterized by a discontinuous 30-amino-acid deletion in NSP2. This deletion serves as a molecular marker but does not solely determine virulence [15]. Recent surveillance in Peru identified sublineage 1A strains with unique N-glycosylation patterns and recombination breakpoints, underscoring ongoing evolution in South American populations [2].

3. Phylogenetic Analysis of ORF5

3.1 ORF5 as a Molecular Epidemiology Marker

ORF5 encodes GP5, the major envelope glycoprotein containing primary neutralizing epitopes. At approximately 600 nucleotides, ORF5 provides sufficient phylogenetic signal for strain discrimination while remaining amenable to high-throughput Sanger sequencing. The gene exhibits a substitution rate of approximately 10⁻³ substitutions per site per year, enabling resolution of transmission chains at the farm and regional levels [2, 15].

3.2 Phylogenetic Reconstruction Methodologies

Maximum likelihood (ML) inference under the general time-reversible (GTR) model with gamma-distributed rate heterogeneity (GTR+Γ) represents the standard for ORF5 phylogenetics. Bayesian inference using Markov chain Monte Carlo (MCMC) sampling provides posterior probability support for clade assignments. Temporal signal assessment via root-to-tip regression in TempEst validates molecular clock assumptions prior to time-scaled phylogeny estimation in BEAST [2, 15].

Recombination detection constitutes a critical preprocessing step. Algorithms including RDP, GENECONV, BootScan, MaxChi, Chimaera, SiScan, and 3Seq implemented in RDP4 identify recombination breakpoints with high sensitivity. Recombinant sequences are either excluded or analyzed as separate partitions to avoid topological artifacts [2].

3.3 Phylogeographic and Phylodynamic Inference

Discrete trait analysis (DTA) in BEAST reconstructs viral migration between geographic regions or production systems using asymmetric continuous-time Markov chain models. Bayesian stochastic search variable selection (BSSVS) identifies statistically supported migration routes. Effective population size trajectories estimated via skygrid or skyride coalescent models correlate with epidemic dynamics and intervention impacts [15].

A retrospective analysis of swine abortion materials in Germany (2021–2023) demonstrated the utility of ORF5 sequencing for detecting PRRSV alongside other reproductive pathogens, revealing co-circulation dynamics relevant to differential diagnosis [3].

4. Machine Learning for Strain Typing and Phenotype Prediction

4.1 Feature Engineering from Genomic Data

Machine learning classifiers require numerical representation of sequence data. Common approaches include:

• k-mer frequency vectors: Counts of all possible subsequences of length k (typically k=3 to 6) normalized by sequence length
• Position-specific scoring matrices (PSSMs): Conservation scores at each alignment position derived from multiple sequence alignments
• Physicochemical property encodings: Amino acid indices representing hydrophobicity, charge, volume, and secondary structure propensity
• Embedding vectors: Learned representations from protein language models (e.g., ESM-2, ProtBERT) capturing evolutionary and structural constraints

4.2 Supervised Classification Architectures

Random forest (RF) and gradient boosting machines (XGBoost, LightGBM) achieve high accuracy for lineage and sublineage assignment using ORF5 or whole-genome features. RF provides feature importance metrics identifying discriminatory residues. Support vector machines (SVMs) with radial basis function kernels perform well on smaller datasets. Deep learning architectures including convolutional neural networks (CNNs) and transformer models process raw sequences or embeddings for end-to-end classification [2, 15].

A targeted next-generation sequencing panel validated for swine respiratory pathogens demonstrated that machine learning classifiers trained on panel data could differentiate PRRSV lineages with >95 percent accuracy, enabling rapid strain typing directly from clinical samples [8].

4.3 Phenotype Prediction: Virulence and Vaccine Escape

Regression models predict continuous phenotypes such as viral load, mortality rate, or neutralization titer from sequence features. Classification models predict categorical outcomes: high versus low pathogenicity, vaccine breakthrough versus protection. SHAP (SHapley Additive exPlanations) values interpret model predictions at the residue level, identifying putative virulence determinants and antigenic sites [15].

The Korean NADC30-like strain associated with high fever and mortality exhibited specific amino acid substitutions in GP5 and NSP2 that machine learning models flagged as high-risk virulence signatures, demonstrating translational utility [15].

4.4 Unsupervised Learning for Novel Variant Detection

Autoencoders and variational autoencoders (VAEs) trained on known diversity detect anomalous sequences representing potential novel recombinants or emerging lineages. t-distributed stochastic neighbor embedding (t-SNE) and uniform manifold approximation and projection (UMAP) visualize sequence space structure, revealing clusters corresponding to known lineages and outliers warranting investigation [2].

5. Reverse Vaccinology Approaches

5.1 Principles and Pipeline Architecture

Reverse vaccinology leverages genomic sequences to identify vaccine candidates computationally prior to wet-lab validation. The pipeline comprises:

1. Pan-genome analysis: Core and accessory genome identification across representative strains
2. Subcellular localization prediction: Signal peptides, transmembrane domains, lipoprotein motifs (SignalP, TMHMM, LipoP)
3. Antigenicity prediction: B-cell epitope (BepiPred, ABCpred), T-cell epitope (NetMHCpan, MHCflurry) prediction
4. Conservation analysis: Entropy-based scoring across alignments to identify broadly conserved epitopes
5. Population coverage calculation: HLA/swine leukocyte antigen (SLA) allele frequency weighting for epitope sets
6. Structural modeling: AlphaFold2 or homology modeling for 3D epitope mapping and accessibility assessment
7. Immunogenicity filtering: Host homology exclusion (BLAST against Sus scrofa proteome), allergenicity (AllerTOP), toxicity (ToxinPred) screening

5.2 Structural Protein Targets

GP5 remains the primary target due to its exposure on the virion surface and role in neutralization. However, GP5 exhibits high variability in the primary neutralizing epitope (PNE, residues 32–59). Reverse vaccinology identifies conserved subdomains and conformational epitopes less prone to escape. GP4 and GP3 form a heterodimer with GP5; conserved residues at the GP4-GP5 interface represent promising targets for broadly neutralizing antibodies [9].

The M protein contains conserved linear epitopes recognized by T cells. N protein, while internal, generates strong CD8+ T-cell responses and serves as a marker for DIVA (differentiating infected from vaccinated animals) strategies when deleted from vaccine constructs [13].

5.3 Non-Structural Protein Targets

NSPs mediate immune evasion and represent targets for T-cell vaccines aiming to reduce viral replication. NSP2 exhibits the highest variability but contains conserved domains essential for protease activity and host interaction. NSP1β, NSP4, NSP9 (RNA-dependent RNA polymerase), and NSP10 (helicase) show higher conservation [5, 6, 10, 11].

Recent mechanistic studies reveal NSP2 hijacks host lipophagy via a LIPE-PNPLA2-AMPK-MTOR axis to promote replication [5]. NSP8 suppresses NF-κB signaling by hijacking host UBE2K and IKKα [6]. These host-pathogen interfaces represent targets for attenuated vaccine design through rational mutagenesis.

5.4 Epitope-Based Vaccine Design

Multi-epitope constructs string together predicted B-cell and T-cell epitopes with appropriate linkers (e.g., AAY for CD8+ epitopes, GPGPG for CD4+ epitopes, KK for B-cell epitopes). Adjuvant sequences (e.g., TLR5 agonist flagellin D0/D1 domains) enhance immunogenicity. Codon optimization for Sus scrofa expression, mRNA secondary structure minimization, and innate immune sensor avoidance (e.g., CpG depletion) optimize in vivo expression [9, 12].

Lectin-based antiviral strategies targeting viral glycans offer complementary approaches. Griffithsin, a high-mannose oligosaccharide-binding lectin, suppresses PRRSV-2 replication in vitro and reduces early viremia in vivo by blocking GP5-glycan interactions with host receptors [9].

6. Genomic Surveillance Workflows

6.1 Sample-to-Sequence Pipelines

flowchart TD
    A[Clinical Sample Collection], > B[RNA Extraction]
    B, > C{Sequencing Strategy}
    C, >|Targeted Amplicon| D[Multiplex RT-PCR / Probe Capture]
    C, >|Metagenomic| E[Random Priming / rRNA Depletion]
    D, > F[Library Preparation]
    E, > F
    F, > G[High-Throughput Sequencing]
    G, > H[Base Calling & Quality Control]
    H, > I[Host Read Removal]
    I, > J[De Novo Assembly / Reference Mapping]
    J, > K[Consensus Genome Generation]
    K, > L[Quality Assessment: Coverage, Completeness]
    L, > M[Lineage Assignment]
    M, > N[Recombination Detection]
    N, > O[Phylogenetic Placement]
    O, > P[Transmission Inference]
    P, > Q[Database Submission & Reporting]

Figure 1: Bioinformatics workflow for PRRSV genomic surveillance from sample collection to phylogenetic reporting.

6.2 Targeted Sequencing Panels

Hybridization capture or multiplex amplicon panels enrich PRRSV sequences from clinical samples with low viral loads. A validated panel targeting common and emerging swine respiratory pathogens achieved >99 percent genome coverage at 1000× mean depth for PRRSV, enabling minority variant detection at 1 percent frequency [8]. Probe sets designed from diverse reference genomes mitigate reference bias.

6.3 Real-Time Analytics and Data Integration

Cloud-based platforms (e.g., Nextstrain, Pathogenwatch) adapted for veterinary pathogens enable automated phylogenetic placement of new sequences within global context. Integration with farm metadata (location, production type, vaccination history, animal movement records) supports phylodynamic inference. Automated alerting for novel recombinants, vaccine-like strains, or high-pathogenicity signatures informs intervention decisions [7, 14].

Environmental sampling of manure pits and aerosol collectors provides population-level surveillance with reduced animal handling. A pilot study investigating manure pit management procedures demonstrated correlations between pit agitation events and detectable viremia changes, suggesting environmental RNA as a herd-level monitoring tool [7].

Sample stability under field conditions affects sequencing success. Filter paper-based sampling evaluated across temperature, relative humidity, and time gradients showed PRRSV RNA remains detectable for up to 21 days at ambient conditions, supporting mail-in surveillance programs [14].

7. Vaccine Design Strategies Informed by Bioinformatics

7.1 Modified Live Virus (MLV) Vaccines

Current MLV vaccines derive from serial passage attenuation. Whole-genome sequencing of vaccine strains and field isolates identifies reversion mutations and recombination events between vaccine and field strains. Bioinformatics-guided attenuation targets specific virulence determinants (e.g., NSP2 deletions, NSP1β interferon antagonism motifs) while preserving immunogenicity [13].

Reverse genetics systems based on circular polymerase extension reaction (CPER) enable rapid generation of recombinant viruses with defined mutations for vaccine candidate testing [13].

7.2 Subunit and Vectored Vaccines

GP5-M-N fusion proteins expressed in baculovirus, adenovirus, or alphavirus replicon vectors elicit neutralizing antibodies and T-cell responses. Structure-guided design stabilizes GP5 in prefusion conformation. Mosaic antigens computationally designed from diverse lineages maximize epitope coverage [9, 12].

7.3 mRNA and Self-Amplifying RNA Vaccines

mRNA vaccines encoding conserved epitope sets or full-length structural proteins offer rapid adaptability. Codon optimization, modified nucleotides (1-methylpseudouridine), and lipid nanoparticle formulation enhance translation and reduce reactogenicity. Self-amplifying RNA (saRNA) replicons derived from alphaviruses achieve equivalent immunogenicity at lower doses [9].

7.4 DIVA-Compatible Vaccines

Deletion of immunodominant but non-protective epitopes (e.g., N protein, NSP2 hypervariable region) enables serological differentiation. Companion ELISAs targeting deleted antigens detect field exposure in vaccinated populations. Bioinformatics identifies optimal deletion boundaries preserving structural integrity and replication competence for MLV platforms [13].

7.5 Adjuvant and Delivery Optimization

Computational screening of adjuvant candidates (TLR agonists, STING agonists, cytokine fusions) predicts Th1/Th2 bias. Nanoparticle display of epitopes in repetitive arrays enhances B-cell receptor cross-linking. In silico modeling of lymph node drainage kinetics informs dosing schedules [12].

8. Host-Virus Interaction Networks and Systems Vaccinology

8.1 Transcriptomic and Proteomic Signatures

RNA-seq of PRRSV-infected porcine alveolar macrophages (PAMs) and MARC-145 cells reveals dynamic host responses. Differential expression analysis identifies pathways modulated by viral proteins: interferon signaling, apoptosis, autophagy, lipid metabolism, and antigen presentation [5, 6, 11, 12].

MicroRNA profiling uncovered miR-378b-3p promoting PRRSV replication by targeting OGT (O-GlcNAc transferase), suppressing type I interferon expression [11]. Myricetin, a natural flavonoid, activates innate antiviral immunity in MARC-145 cells during infection, suggesting host-directed therapeutic adjuncts [12].

8.2 Network-Based Target Prioritization

Protein-protein interaction (PPI) networks integrating viral and host proteins identify bottleneck nodes. NSP2-NSP3 heterodimerization regulates cytoplasmic tail binding to the viral RdRp domain for subgenomic RNA synthesis [10]. Host factors recruited to replication-transcription complexes (RTCs) represent targets for broad-spectrum antivirals and attenuated vaccine design.

8.3 Systems Vaccinology for Correlates of Protection

Multi-omics profiling (transcriptome, proteome, metabolome, immunophenotyping) of vaccinated and challenged pigs identifies molecular signatures correlating with protection. Machine learning models trained on these datasets predict vaccine efficacy from early post-vaccination timepoints, accelerating candidate down-selection [4, 12].

9. Challenges and Future Directions

9.1 Data Standardization and Sharing

Lack of standardized metadata schemas (sample origin, clinical presentation, vaccination status, sequencing protocol) hampers meta-analyses. Adoption of MIxS (Minimum Information about any (x) Sequence) extensions for veterinary pathogens and deposition in public repositories (GenBank, ENA, GISAID) with rich metadata will enhance global surveillance.

9.2 Computational Resource Requirements

Whole-genome sequencing generates terabyte-scale datasets. Cloud computing and containerized workflows (Nextflow, Snakemake, WDL) enable reproducible, scalable analysis. Federated learning approaches allow model training across distributed datasets without raw data transfer, addressing privacy and bandwidth constraints.

9.3 Evolutionary Forecasting

Integrating phylogenetic, structural, and immunological data into predictive models of antigenic evolution remains challenging. Deep mutational scanning of GP5 combined with neutralization assays from polyclonal sera can parameterize fitness landscapes for in silico evolution simulations.

9.4 Cross-Species and One Health Considerations

While PRRSV is swine-specific, arteriviruses infect diverse mammals (equine arteritis virus, simian hemorrhagic fever virus, wobbly possum disease virus). Comparative genomics across Arteriviridae identifies conserved vulnerabilities. Surveillance at wildlife-livestock interfaces monitors for spillover events, though no natural non-suid reservoirs are known for PRRSV [1].

10. Conclusion

Bioinformatics has become indispensable for PRRS genomic surveillance and vaccine development. Phylogenetic analysis of ORF5 provides the backbone for molecular epidemiology, while whole-genome approaches resolve transmission dynamics and recombination. Machine learning transforms sequence data into actionable strain typing and phenotype prediction. Reverse vaccinology pipelines translate genomic diversity into rationally designed vaccine candidates targeting conserved epitopes across structural and non-structural proteins. Integration of host-pathogen interaction networks with systems vaccinology will define correlates of protection and accelerate next-generation vaccine deployment. Sustained investment in data infrastructure, standardized workflows, and interdisciplinary collaboration is essential to mitigate the evolving threat of PRRS to global swine health.

References

[1] Gyurján I, Sipos-Kozma Z, Ásványi B et al. Development and validation of an LNA-based one-step multiplex RT-qPCR assay for differentiating Betaarterivirus europensis (PRRSV-1), Betaarterivirus americense (PRRSV-2), and the highly pathogenic L8 lineage of PRRSV-2. Vet J. 2026. https://pubmed.ncbi.nlm.nih.gov/42235629/

[2] Cotaquispe Nalvarte RY, Legua Barrios M, De la Cruz Vásquez E et al. Genetic variability, N-glycosylation, and recombination in sublineage 1A of Betaarterivirus americense from commercial pig farms in Lima, 2019. Front Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42232907/

[3] Bischoff H, Beumer M, Helmer C et al. Retrospective analysis of infectious agents in swine abortion materials in the years 2021 to 2023. Vet Res Commun. 2026. https://pubmed.ncbi.nlm.nih.gov/42213157/

[4] Tran HT, Mercado AJ, Lahoti MM et al. Effects of a novel feed additive on clinical symptoms and the nasal and cecal microbiome in nursery pigs challenged with PRRSV and Streptococcus suis. Transl Anim Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42211862/

[5] Zhu Z, Lin Q, Zhang X et al. PRRSV NSP2 hijacks host lipophagy via a LIPE-PNPLA2-AMPK-MTOR axis to promote viral replication. Autophagy. 2026. https://pubmed.ncbi.nlm.nih.gov/42200529/

[6] Liu D, Yan Y, Fu X et al. Porcine Reproductive and Respiratory Syndrome Virus NSP8 Suppresses NF-κB Signaling by Hijacking Host UBE2K and IKKα. Viruses. 2026. https://pubmed.ncbi.nlm.nih.gov/42198770/

[7] Melini CM, Kikuti M, Yue X et al. An Exploratory Pilot Study to Investigate the Potential Relationship Between Porcine Reproductive and Respiratory Syndrome (PRRS) Virus Viremia Changes and Barn Manure Pit Management Procedures. Pathogens. 2026. https://pubmed.ncbi.nlm.nih.gov/42198580/

[8] Elshafie NO, Wilkes RP. Analytic and Diagnostic Validation of a Targeted Next-Generation Sequencing Panel for Common and Emerging Swine Respiratory Pathogens. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/42197544/

[9] Kadekar D, Velayudhan D, Vinyeta E et al. Lectin-Based Antiviral Strategies for Porcine Reproductive and Respiratory Syndrome Virus 2 Infection: Griffithsin Suppresses Viral Replication In Vitro and Reduces Early Viremia In Vivo. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/42197483/

[10] Liu X, Hu Y, Zhou Q et al. Heterodimerization of PRRSV replicase membrane proteins nsp2 and nsp3 regulates their cytoplasmic tail binding to viral RdRp domain for sgRNA synthesis. J Virol. 2026. https://pubmed.ncbi.nlm.nih.gov/42187313/

[11] Zhang X, Yao Y, Guo SY et al. miR-378b-3p promotes porcine reproductive and respiratory syndrome virus replication by negatively regulating type I interferon expression via targeting OGT. J Immunol. 2026. https://pubmed.ncbi.nlm.nih.gov/42187089/

[12] Wang A, Chen W, Wang B et al. Myricetin activates innate antiviral immunity during PRRSV infection in MARC-145 cells. Vet Immunol Immunopathol. 2026. https://pubmed.ncbi.nlm.nih.gov/42184610/

[13] Hassanien RT, Dittmar W, Balasuriya UBR et al. Reverse genetics approach for arteriviruses using circular polymerase extension reaction. Access Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42181111/

[14] Armenta-Leyva B, Munguía-Ramírez B, Zhang Y et al. Effect of temperature, relative humidity, and time on the detection of swine RNA viruses (PRRSV, PEDV, IAV) inoculated onto filter papers. Front Cell Infect Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42180247/

[15] Ham S, Suh J, Na H et al. Genetic and pathogenic characterization of a Korean NADC30-like PRRSV strain associated with high fever and mortality. Vet Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42172873/